Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 49, 2020 - Issue 1-2
392
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Increases of CD80 and CD86 Expression on Peripheral Blood Cells and their Gene Polymorphisms in Autoimmune Thyroid Disease

, , ORCID Icon, , , & ORCID Icon show all

References

  • Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, et al. 2006. A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis. Int J Immunogenet. 33:155–61.
  • Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C. 1993a. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 366:76–79.
  • Azuma M, Yssel H, Phillips JH, Spits H, Lanier LL. 1993b. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med. 177:845–50.
  • Bossowski A, Stasiak-Barmuta A, Urban M. 2005. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves’ disease. Horm Res. 64:189–97.
  • Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein P. 1987. A new member of the immunoglobulin superfamily–CTLA-4. Nature. 328:267–70.
  • Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL, Banchereau J. 1994. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med. 180:1841–47.
  • Dariavach P, Mattei MG, Golstein P, Lefranc MP. 1988. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol. 18:1901–05.
  • Fleischer J, Soeth E, Reiling N, Grage-Griebenow E, Flad HD, Ernst M. 1996. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology. 89:592–98.
  • Gao JF, McIntyre MS, Juvet SC, Diao J, Li X, Vanama RB, Mak TW, Cattral MS, Zhang L. 2011. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells. Eur J Immunol. 41:2699–708.
  • Genc K, Dona DL, Reder AT. 1997. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J Clin Invest. 99:2664–71.
  • Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med. 180:631–40.
  • Hayashi F, Watanabe M, Nanba T, Inoue N, Akamizu T, Iwatani Y. 2009. Association of the −31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves’ disease and the proportion of T helper type 17 cells. Clin Exp Immunol. 158:281–86.
  • Huang Y, Li Y, Wei B, Wu W, Gao X. 2018. CD80 regulates Th17 cell differentiation in coxsackie virus B3-induced acute myocarditis. Inflammation. 41:232–39.
  • Inoue N, Watanabe M, Morita M, Tatusmi K, Hidaka Y, Akamizu T, Iwatani Y. 2011. Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol. 163:318–23.
  • Inoue N, Watanabe M, Morita M, Tomizawa R, Akamizu T, Tatsumi K, Hidaka Y, Iwatani Y. 2010. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol. 162:402–06.
  • Inoue N, Watanabe M, Yamada H, Takemura K, Hayashi F, Yamakawa N, Akahane M, Shimizuishi Y, Hidaka Y, Iwatani Y. 2012. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J Clin Immunol. 32:1243–52.
  • Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y. 2006. Association between the severity of Hashimoto’s disease and the functional +874A/T polymorphism in the interferon-gamma gene. Endocr J. 53:473–78.
  • Jacobson EM, Tomer Y. 2007. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun. 28:85–98.
  • Janeway CA Jr., Bottomly K. 1994. Signals and signs for lymphocyte responses. Cell. 76:275–85.
  • Jenkins M. 1994. The ups and downs of T cell costimulation. Immunity. 1:443–46.
  • Lanier LL, O’Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol. 154:97–105.
  • Leung HT, Bradshaw J, Cleaveland JS, Linsley PS. 1995. Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J Biol Chem. 270:25107–14.
  • Liao WL, Chen RH, Lin HJ, Liu YH, Chen WC, Tsai Y, Wan L, Tsai FJ. 2011. The association between polymorphisms of B7 molecules (CD80 and CD86) and Graves’ ophthalmopathy in a Taiwanese population. Ophthalmology. 118:553–57.
  • Liu ZX, Hiwatashi N, Noguchi M, Toyota T. 1997. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn’s disease. Scand J Gastroenterol. 32:1241–46.
  • McCoy KD, Le Gros G. 1999. The role of CTLA-4 in the regulation of T cell immune responses. Immunol Cell Biol. 77:1–10.
  • Menconi F, Marcocci C, Marino M. 2014. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 13:398–402.
  • Menezes SM, Decanine D, Brassat D, Khouri R, Schnitman SV, Kruschewsky R, Lopez G, Alvarez C, Talledo M, Gotuzzo E, et al. 2014. CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis. J Neuroinflammation. 11:18.
  • Nanba T, Watanabe M, Akamizu T, Iwatani Y. 2008. The −590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin Chem. 54:621–23.
  • Nanba T, Watanabe M, Inoue N, Iwatani Y. 2009. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid. 19:495–501.
  • Norcross M. 1984. A synaptic basis for T-lymphocyte activation. Ann Immunol (Paris). 135D:113–34.
  • Pruul K, Kisand K, Alnek K, Metskula K, Heilman K, Peet A, Varik K, Uibo R. 2013. Expression of B7 and CD28 family genes in newly diagnosed type 1 diabetes. Hum Immunol. 74:1251–57.
  • Smith TR, Verdeil G, Marquardt K, Sherman LA. 2014. Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms. J Immunol. 193:3409–16.
  • Wang C, Gui Q, Zhang K. 2015. Functional polymorphisms in CD86 gene are associated with susceptibility to pneumonia-induced sepsis. Apmis. 123:433–38.
  • Weetman A. 2013. The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. Eur Thyroid J. 1:243–50.
  • Wu D, Tang R, Qi Q, Zhou X, Zhou H, Mao Y, Li R, Liu C, Wang W, Hua D, et al. 2014a. Five functional polymorphisms of B7/CD28 co-signaling molecules alter susceptibility to colorectal cancer. Cell Immunol. 293:41–48.
  • Wu R, Li F, Zhu J, Tang R, Qi Q, Zhou X, Li R, Wang W, Hua D, Chen W. 2014b. A functional variant at miR-132-3p, miR-212-3p, and miR-361-5p binding site in CD80 gene alters susceptibility to gastric cancer in a Chinese Han population. Med Oncol. 31:60.
  • Xiang H, Zhao W, Sun Y, Qian W, Xing J, Zhou Y, Yao J, Xu J, Wang Y, Yao H, et al. 2012. CD86 gene variants and susceptibility to pancreatic cancer. J Cancer Res Clin Oncol. 138:2061–67.
  • Yamada H, Watanabe M, Nanba T, Akamizu T, Iwatani Y. 2008. The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin Exp Immunol. 151:379–82.
  • Yamamoto M, Watanabe M, Inoue N, Watanabe A, Ozaki H, Ohsaki M, Hidaka Y, Iwatani Y. 2019. Association of CD58 polymorphisms and its protein expression with the development and prognosis of autoimmune thyroid diseases. Immunol Invest. 1–14. doi:10.1080/08820139.2019.1659811
  • Young JW, Koulova L, Soergel SA, Clark EA, Steinman RM, Dupont B. 1992. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J Clin Invest. 90:229–37.
  • Zhang Y, Yang J, Zhang J, Sun L, Hirankarn N, Pan HF, Lau CS, Chan TM, Lee TL, Leung AM, et al. 2015. Genome-wide search followed by replication reveals genetic interaction of CD80 and ALOX5AP associated with systemic lupus erythematosus in Asian populations. Ann Rheum Dis. 75:891–98.
  • Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol. 172:2778–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.